| II-37 Luzelena Caro Population Pharmacokinetics Modeling Characterizes the Higher Grazoprevir Exposure in Japanese Compared to Non-Japanese HCV-Infected Patients Wednesday 15:10-16:30 |
| II-37 Luzelena Caro Population Pharmacokinetics Modeling Characterizes the Higher Grazoprevir Exposure in Japanese Compared to Non-Japanese HCV-Infected Patients Wednesday 15:10-16:30 |